Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- DOE - Office Of Science; INDUSTRY
- OSTI ID:
- 1863056
- Journal Information:
- J. Med. Chem., Vol. 65, Issue (6)
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor
Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2
Journal Article
·
2022
· J. Med. Chem.
·
OSTI ID:1863056
+22 more
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor
Journal Article
·
2017
· Journal of Medicinal Chemistry
·
OSTI ID:1863056
+24 more
Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2
Journal Article
·
2016
· Bioorganic and Medicinal Chemistry Letters
·
OSTI ID:1863056
+9 more